[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0617602D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB0617602D0
GB0617602D0 GBGB0617602.8A GB0617602A GB0617602D0 GB 0617602 D0 GB0617602 D0 GB 0617602D0 GB 0617602 A GB0617602 A GB 0617602A GB 0617602 D0 GB0617602 D0 GB 0617602D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0617602.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB0617602.8A priority Critical patent/GB0617602D0/en
Publication of GB0617602D0 publication Critical patent/GB0617602D0/en
Priority to EP07803333.9A priority patent/EP2066344B2/en
Priority to US12/440,054 priority patent/US8945582B2/en
Priority to DK07803333.9T priority patent/DK2066344T3/en
Priority to PCT/EP2007/059391 priority patent/WO2008028957A2/en
Priority to BRPI0716519-6A2A priority patent/BRPI0716519A2/en
Priority to BRPI0716518A priority patent/BRPI0716518B8/en
Priority to PL07803333T priority patent/PL2066344T3/en
Priority to EP07803334A priority patent/EP2097102B1/en
Priority to KR1020097007118A priority patent/KR20090057423A/en
Priority to PL07803334T priority patent/PL2097102T3/en
Priority to AT07803333T priority patent/ATE511398T1/en
Priority to PCT/EP2007/059390 priority patent/WO2008028956A1/en
Priority to MX2009002561A priority patent/MX2009002561A/en
Priority to PT07803334T priority patent/PT2097102E/en
Priority to PT07803333T priority patent/PT2066344E/en
Priority to DK07803334.7T priority patent/DK2097102T3/en
Priority to JP2009527147A priority patent/JP5814507B2/en
Priority to CN200780041465.XA priority patent/CN101534855B/en
Priority to JP2009527148A priority patent/JP2010502679A/en
Priority to NZ575273A priority patent/NZ575273A/en
Priority to CNA2007800414575A priority patent/CN101534854A/en
Priority to UAA200901646A priority patent/UA95810C2/en
Priority to EA200900289A priority patent/EA016417B1/en
Priority to CA002662064A priority patent/CA2662064A1/en
Priority to ES07803333.9T priority patent/ES2365557T5/en
Priority to EA200900288A priority patent/EA015964B1/en
Priority to MX2009002560A priority patent/MX2009002560A/en
Priority to NZ575272A priority patent/NZ575272A/en
Priority to AU2007293673A priority patent/AU2007293673B2/en
Priority to ES07803334T priority patent/ES2387582T3/en
Priority to CN201310235178XA priority patent/CN103357003A/en
Priority to SI200730635T priority patent/SI2066344T1/en
Priority to US12/440,043 priority patent/US8956625B2/en
Priority to AU2007293672A priority patent/AU2007293672B2/en
Priority to UAA200901962A priority patent/UA97376C2/en
Priority to EP12169665A priority patent/EP2491947A3/en
Priority to CA002662051A priority patent/CA2662051A1/en
Priority to CN201310079459.0A priority patent/CN103585624A/en
Priority to SI200730990T priority patent/SI2097102T1/en
Priority to KR1020097007120A priority patent/KR20090058552A/en
Priority to NO20090865A priority patent/NO20090865L/en
Priority to IL197310A priority patent/IL197310A/en
Priority to IL197272A priority patent/IL197272A/en
Priority to NO20090897A priority patent/NO20090897L/en
Priority to ZA200901530A priority patent/ZA200901530B/en
Priority to ZA200901592A priority patent/ZA200901592B/en
Priority to CO09023294A priority patent/CO6160334A2/en
Priority to CO09023296A priority patent/CO6160335A2/en
Priority to MA31725A priority patent/MA30715B1/en
Priority to MA31726A priority patent/MA30716B1/en
Priority to CR10669A priority patent/CR10669A/en
Priority to CR10672A priority patent/CR10672A/en
Priority to HK09106864.1A priority patent/HK1129563A1/en
Priority to HR20110431T priority patent/HRP20110431T1/en
Priority to CY20111100621T priority patent/CY1111680T1/en
Priority to HRP20120557TT priority patent/HRP20120557T1/en
Priority to CY20121100696T priority patent/CY1113419T1/en
Priority to JP2013149549A priority patent/JP2013256505A/en
Priority to JP2014182142A priority patent/JP2015028041A/en
Priority to US14/579,353 priority patent/US20150273047A1/en
Priority to JP2015158139A priority patent/JP2016020361A/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0617602.8A 2006-09-07 2006-09-07 Vaccine Ceased GB0617602D0 (en)

Priority Applications (62)

Application Number Priority Date Filing Date Title
GBGB0617602.8A GB0617602D0 (en) 2006-09-07 2006-09-07 Vaccine
EP07803333.9A EP2066344B2 (en) 2006-09-07 2007-09-07 Inactivated Poliovirus combination vaccine
US12/440,054 US8945582B2 (en) 2006-09-07 2007-09-07 Vaccine
DK07803333.9T DK2066344T3 (en) 2006-09-07 2007-09-07 Inactivated Poliovirus combination vaccine
PCT/EP2007/059391 WO2008028957A2 (en) 2006-09-07 2007-09-07 Vaccine
BRPI0716519-6A2A BRPI0716519A2 (en) 2006-09-07 2007-09-07 METHOD FOR MANUFACTURING A VACCINE
BRPI0716518A BRPI0716518B8 (en) 2006-09-07 2007-09-07 ipv vaccine and its use
PL07803333T PL2066344T3 (en) 2006-09-07 2007-09-07 Inactivated Poliovirus combination vaccine
EP07803334A EP2097102B1 (en) 2006-09-07 2007-09-07 Combination vaccine having reduced polio virus antigen quantities
KR1020097007118A KR20090057423A (en) 2006-09-07 2007-09-07 Vaccine
PL07803334T PL2097102T3 (en) 2006-09-07 2007-09-07 Combination vaccine having reduced polio virus antigen quantities
AT07803333T ATE511398T1 (en) 2006-09-07 2007-09-07 INACTIVATED POLIOVIRUS MIXED VACCINE
PCT/EP2007/059390 WO2008028956A1 (en) 2006-09-07 2007-09-07 Vaccine
MX2009002561A MX2009002561A (en) 2006-09-07 2007-09-07 Vaccine.
PT07803334T PT2097102E (en) 2006-09-07 2007-09-07 Combination vaccine having reduced polio virus antigen quantities
PT07803333T PT2066344E (en) 2006-09-07 2007-09-07 Inactivated poliovirus combination vaccine
DK07803334.7T DK2097102T3 (en) 2006-09-07 2007-09-07 Combination vaccine with reduced amounts of poliovirus antigen
JP2009527147A JP5814507B2 (en) 2006-09-07 2007-09-07 vaccine
CN200780041465.XA CN101534855B (en) 2006-09-07 2007-09-07 Vaccine
JP2009527148A JP2010502679A (en) 2006-09-07 2007-09-07 vaccine
NZ575273A NZ575273A (en) 2006-09-07 2007-09-07 Method for making combination vaccine comprising inactivated poliovirus type 1, diptheria toxoid and tetanus toxoid
CNA2007800414575A CN101534854A (en) 2006-09-07 2007-09-07 Vaccine
UAA200901646A UA95810C2 (en) 2006-09-07 2007-09-07 Inactivated poliovirus vaccine
EA200900289A EA016417B1 (en) 2006-09-07 2007-09-07 Method of making vaccine
CA002662064A CA2662064A1 (en) 2006-09-07 2007-09-07 Method of producing a combination polivirus vaccine
ES07803333.9T ES2365557T5 (en) 2006-09-07 2007-09-07 Inactivated Poliovirus Combination Vaccines
EA200900288A EA015964B1 (en) 2006-09-07 2007-09-07 Vaccine
MX2009002560A MX2009002560A (en) 2006-09-07 2007-09-07 Vaccine.
NZ575272A NZ575272A (en) 2006-09-07 2007-09-07 Inactivated poliovirus type 1, diptheria toxoid, tetanus toxoid and killed whole-cell Bordetella pertussis vaccine
AU2007293673A AU2007293673B2 (en) 2006-09-07 2007-09-07 Vaccine
ES07803334T ES2387582T3 (en) 2006-09-07 2007-09-07 Combination vaccine with reduced amounts of polio virus antigen
CN201310235178XA CN103357003A (en) 2006-09-07 2007-09-07 Vaccine
SI200730635T SI2066344T1 (en) 2006-09-07 2007-09-07 Inactivated Poliovirus combination vaccine
US12/440,043 US8956625B2 (en) 2006-09-07 2007-09-07 Inactivated polio vaccines
AU2007293672A AU2007293672B2 (en) 2006-09-07 2007-09-07 Vaccine
UAA200901962A UA97376C2 (en) 2006-09-07 2007-09-07 Vaccine
EP12169665A EP2491947A3 (en) 2006-09-07 2007-09-07 Vaccine
CA002662051A CA2662051A1 (en) 2006-09-07 2007-09-07 Vaccine
CN201310079459.0A CN103585624A (en) 2006-09-07 2007-09-07 Vaccine
SI200730990T SI2097102T1 (en) 2006-09-07 2007-09-07 Combination vaccine having reduced polio virus antigen quantities
KR1020097007120A KR20090058552A (en) 2006-09-07 2007-09-07 Vaccine
NO20090865A NO20090865L (en) 2006-09-07 2009-02-25 Vaccine
IL197310A IL197310A (en) 2006-09-07 2009-02-26 Method for making a vaccine comprising inactivated poliovirus type 1
IL197272A IL197272A (en) 2006-09-07 2009-02-26 Ip vaccine for immunizing a human and uses thereof in the manufacture of a medicament for the prevention of disease caused by poliovirus, clostridium tetani, corynebacterium diphtheria and bordetella pertussis
NO20090897A NO20090897L (en) 2006-09-07 2009-02-26 Vaccine
ZA200901530A ZA200901530B (en) 2006-09-07 2009-03-03 Vaccine
ZA200901592A ZA200901592B (en) 2006-09-07 2009-03-05 Vaccine
CO09023294A CO6160334A2 (en) 2006-09-07 2009-03-06 METHOD FOR THE ELABORATION OF A CONBINATION VACCINE TO PROTECT AGAINST POLIO
CO09023296A CO6160335A2 (en) 2006-09-07 2009-03-06 VACCINE
MA31725A MA30715B1 (en) 2006-09-07 2009-03-18 VACCINE
MA31726A MA30716B1 (en) 2006-09-07 2009-03-18 VACCINE
CR10669A CR10669A (en) 2006-09-07 2009-03-18 VACCINE
CR10672A CR10672A (en) 2006-09-07 2009-03-19 VACCINE
HK09106864.1A HK1129563A1 (en) 2006-09-07 2009-07-24 Inactivated poliovirus combination vaccine
HR20110431T HRP20110431T1 (en) 2006-09-07 2011-06-09 Inactivated poliovirus combination vaccine
CY20111100621T CY1111680T1 (en) 2006-09-07 2011-06-28 Vaccine Vaccine Combined Vaccine Vaccine
HRP20120557TT HRP20120557T1 (en) 2006-09-07 2012-07-06 Combination vaccine having reduced polio virus antigen quantities
CY20121100696T CY1113419T1 (en) 2006-09-07 2012-08-03 Combination vaccine that has reduced quantities of antigenic poliomyelitis virus
JP2013149549A JP2013256505A (en) 2006-09-07 2013-07-18 Vaccine
JP2014182142A JP2015028041A (en) 2006-09-07 2014-09-08 Vaccine
US14/579,353 US20150273047A1 (en) 2006-09-07 2014-12-22 Vaccine
JP2015158139A JP2016020361A (en) 2006-09-07 2015-08-10 vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0617602.8A GB0617602D0 (en) 2006-09-07 2006-09-07 Vaccine

Publications (1)

Publication Number Publication Date
GB0617602D0 true GB0617602D0 (en) 2006-10-18

Family

ID=37232508

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0617602.8A Ceased GB0617602D0 (en) 2006-09-07 2006-09-07 Vaccine

Country Status (5)

Country Link
CN (2) CN101534855B (en)
ES (1) ES2365557T5 (en)
GB (1) GB0617602D0 (en)
UA (2) UA95810C2 (en)
ZA (2) ZA200901530B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8945582B2 (en) 2006-09-07 2015-02-03 Glaxosmithkline Biologicals S.A. Vaccine

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112138155B (en) * 2019-06-28 2022-04-12 怡道生物科技(苏州)有限公司 Compound adjuvant system and method for preparing adjuvant
CN111467488B (en) * 2020-04-17 2023-09-01 内蒙古必威安泰生物科技有限公司 Water-soluble composite immunoadjuvant and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100287083B1 (en) * 1992-05-23 2001-04-16 장 스테판느 Combination vaccine comprising hepatitis B surface antigen and other antigens
CN100408095C (en) * 1996-07-02 2008-08-06 康诺特实验室有限公司 Multivalent DTP-POLID vaccines
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8945582B2 (en) 2006-09-07 2015-02-03 Glaxosmithkline Biologicals S.A. Vaccine
US8956625B2 (en) 2006-09-07 2015-02-17 Glaxosmithkline Biologicals, S.A. Inactivated polio vaccines

Also Published As

Publication number Publication date
ZA200901530B (en) 2010-05-26
CN101534854A (en) 2009-09-16
UA95810C2 (en) 2011-09-12
UA97376C2 (en) 2012-02-10
CN101534855A (en) 2009-09-16
ES2365557T5 (en) 2016-12-07
ZA200901592B (en) 2010-06-30
ES2365557T3 (en) 2011-10-06
CN101534855B (en) 2017-08-01

Similar Documents

Publication Publication Date Title
GB0607088D0 (en) Vaccine
GB0717911D0 (en) Vaccine
GB0616306D0 (en) Vaccines
GB0700135D0 (en) Vaccine
GB0711858D0 (en) Vaccine
HK1129836A1 (en) Ipv-dpt vaccine ipv-dpt
GB0710538D0 (en) Vaccine
GB0614460D0 (en) Vaccines
ZA200901592B (en) Vaccine
GB0625593D0 (en) Vaccine
GB0709373D0 (en) BCG-based anti-atheroma vaccine
GB0619824D0 (en) Vaccine
GB0620336D0 (en) Vaccine
GB0619826D0 (en) Vaccine
GB0619822D0 (en) Vaccine
GB0620337D0 (en) Vaccine
GB0620815D0 (en) Vaccine
GB0620816D0 (en) vaccine
GB0619821D0 (en) Vaccine
GB0619820D0 (en) Vaccine
GB0614476D0 (en) Vaccine
GB0614254D0 (en) Vaccine
GB0608962D0 (en) Vaccine
GB0607087D0 (en) Vaccine
GB0606256D0 (en) Anti-atheroma vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)